1. Home
  2. NX vs PHAR Comparison

NX vs PHAR Comparison

Compare NX & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$16.94

Market Cap

760.6M

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$14.17

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
PHAR
Founded
1927
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
760.6M
885.7M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
NX
PHAR
Price
$16.94
$14.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$28.00
$38.33
AVG Volume (30 Days)
446.3K
4.4K
Earning Date
06-04-2026
05-07-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
N/A
Revenue This Year
$4.26
$10.04
Revenue Next Year
$1.77
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
43.81
N/A
52 Week Low
$11.04
$9.54
52 Week High
$22.90
$21.34

Technical Indicators

Market Signals
Indicator
NX
PHAR
Relative Strength Index (RSI) 45.43 62.60
Support Level $16.90 $12.98
Resistance Level $18.07 $14.81
Average True Range (ATR) 0.89 0.39
MACD 0.09 0.21
Stochastic Oscillator 33.69 100.00

Price Performance

Historical Comparison
NX
PHAR

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: